CC CELULARITY
LIVE

Serial Number

88016661

Owner

CELENIV PTE. LTD.

Attorney

Camille M. Miller

First Use Date

Dec 6, 2018

Filing Date

Jun 27, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CC CELULARITY Trademark

Serial Number: 88016661 • Registration: 6125147

CC CELULARITY is a trademark filed by CELENIV PTE. LTD. on June 27, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELENIV PTE. LTD. (13 trademarks)

3, LIM TECK KIM ROAD
SINGAPORE 088934 , SG

Entity Type: 11

CELULARITY, INC. (50 trademarks)

33 TECHNOLOGY DRIVE
WARREN, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

June 27, 2018

Registration Date

August 11, 2020

First Use Anywhere

December 6, 2018

First Use in Commerce

December 6, 2018

Published for Opposition

October 30, 2018

Goods & Services

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 7, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 11, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 12, 2022 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 8, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 8, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 9, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 8, 2020 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 22, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 30, 2020 SUPC
USE AMENDMENT FILED
Apr 28, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 28, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2019 EXRA
CORRECTED NOA E-MAILED
Nov 9, 2019 NOAC
SOU EXTENSION 2 GRANTED
Nov 8, 2019 EX2G
DIVISIONAL PROCESSING COMPLETE
Nov 8, 2019 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 8, 2019 AITU
SOU EXTENSION 2 FILED
Oct 29, 2019 EXT2
DIVISIONAL REQUEST RECEIVED
Oct 29, 2019 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Oct 29, 2019 ERTD
SOU TEAS EXTENSION RECEIVED
Oct 29, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2019 EXRA
SOU EXTENSION 1 GRANTED
May 28, 2019 EX1G
SOU EXTENSION 1 FILED
May 28, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
May 28, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 25, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 30, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 10, 2018 NONP
ASSIGNED TO LIE
Sep 23, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 4, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 30, 2018 GNFN
FINAL REFUSAL E-MAILED
Aug 30, 2018 GNFR
FINAL REFUSAL WRITTEN
Aug 30, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 24, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 24, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 24, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2018 NWOS
NEW APPLICATION ENTERED
Jun 30, 2018 NWAP